PT-141 – Research Peptide

PT-141, also known as Bremelanotide, is a synthetic cyclic peptide and selective melanocortin receptor agonist originally developed from the melanocortin peptide Melanotan II. Unlike phosphodiesterase inhibitors or compounds that primarily influence vascular function, PT-141 has been investigated for its effects on central nervous system melanocortin pathways, making it an important research tool for studying neuroendocrine regulation, sexual behavior, appetite, and autonomic physiology.

The melanocortin system plays a fundamental role in numerous physiological processes, including energy homeostasis, pigmentation, inflammation, and reproductive behavior. PT-141 primarily targets melanocortin receptors within the central nervous system, particularly MC4R, where experimental evidence suggests it modulates neural pathways involved in motivation and autonomic signaling.

PT-141 has progressed through extensive preclinical research and multiple human clinical studies, contributing significantly to scientific understanding of melanocortin biology and neuroendocrine physiology.

Research Overview

The melanocortin receptor family consists of five G protein-coupled receptors (MC1R–MC5R), each involved in distinct physiological functions. These receptors respond to endogenous peptides derived from proopiomelanocortin (POMC), including alpha-melanocyte-stimulating hormone (α-MSH) and adrenocorticotropic hormone (ACTH).

PT-141 was developed to investigate the role of melanocortin receptor activation independent of the pigmentation effects associated with earlier compounds. Research has demonstrated that activation of central melanocortin pathways influences complex neurobehavioral and autonomic responses through mechanisms distinct from peripheral vascular regulation.

Because of its receptor selectivity and extensive clinical investigation, PT-141 has become one of the most thoroughly studied melanocortin peptides in translational neuroendocrine research.

Mechanism of Action

PT-141 exerts its biological effects primarily through activation of melanocortin receptors within the central nervous system.

Melanocortin Receptor Activation

Experimental studies indicate PT-141 has activity at several melanocortin receptor subtypes, with particularly important effects involving:

• Melanocortin-4 receptor (MC4R)
• Melanocortin-3 receptor (MC3R)

These receptors participate in regulating autonomic function, energy balance, and neuroendocrine signaling.

Central Nervous System Activity

Unlike compounds that act primarily through peripheral vascular mechanisms, PT-141 influences neuronal pathways within the hypothalamus and other regions of the brain involved in behavioral and autonomic regulation.

Researchers continue to investigate how melanocortin signaling contributes to these complex physiological processes.

Neuroendocrine Regulation

Activation of melanocortin receptors has been shown to influence interactions between multiple neurotransmitter systems, including dopamine and oxytocin pathways.

Current research continues to examine how these interactions contribute to broader neuroendocrine function.

Autonomic Physiology

Experimental investigations suggest melanocortin receptor activation influences autonomic nervous system activity, providing additional insight into the integration of central nervous system and peripheral physiological responses.

Current Scientific Research

PT-141 has been investigated through laboratory studies, animal models, and numerous Phase I–III clinical trials.

Neuroendocrine Research

Much of the published literature focuses on understanding how melanocortin receptor activation regulates:

• Central autonomic pathways
• Neuroendocrine signaling
• Behavioral physiology
• Motivational circuitry

These investigations continue to advance understanding of melanocortin biology.

Melanocortin System Research

Researchers continue to study PT-141 as a model compound for investigating:

• MC3R function
• MC4R signaling
• POMC-derived peptide physiology
• Central melanocortin networks

These findings have expanded knowledge of hypothalamic regulation and metabolic physiology.

Metabolic Research

Because melanocortin receptors play important roles in appetite regulation and energy homeostasis, PT-141 has also contributed to research involving obesity, feeding behavior, and metabolic regulation.

Translational Research

Clinical investigations have helped establish the pharmacology, receptor selectivity, and physiological characteristics of PT-141, making it an important compound for studying central melanocortin signaling in humans.

Potential Research Applications

Current scientific literature is investigating PT-141 in relation to:

• Melanocortin receptor biology
• Neuroendocrine signaling
• Central nervous system physiology
• Autonomic regulation
• Appetite regulation
• Energy homeostasis
• Behavioral neuroscience
• POMC signaling
• Hypothalamic physiology

These represent active areas of scientific investigation and should not be interpreted as established therapeutic indications.

Product Snapshot

Research Category: Melanocortin Receptor Agonist

Alternative Name: Bremelanotide

Primary Molecular Targets:

• Melanocortin-4 Receptor (MC4R)
• Melanocortin-3 Receptor (MC3R)

Research Administration Route: Experimental laboratory use

Development Status: Extensive preclinical and clinical research

Evidence Strength: ★★★★★

Strong mechanistic evidence supported by extensive laboratory investigations and multiple human clinical trials examining melanocortin receptor pharmacology and neuroendocrine physiology.

Key Scientific References

Hadley ME, Dorr RT. Melanocortin Peptides and Their Receptors: Pharmacology and Physiology. Endocrine Reviews.

A foundational review describing the biology of melanocortin peptides and receptor subtypes, providing essential background for PT-141 research.

King SH, Mayorov AV, Balse-Srinivasan P, et al. Melanocortin Receptor Agonists: From Molecular Pharmacology to Clinical Investigation. Bioorganic & Medicinal Chemistry.

A comprehensive review examining the development of synthetic melanocortin receptor agonists, including PT-141, and their receptor pharmacology.

Safarinejad MR. Clinical Pharmacology of Bremelanotide in Human Studies. Journal of Sexual Medicine.

A detailed review summarizing human clinical investigations, pharmacokinetics, and receptor-mediated mechanisms of PT-141.

Cone RD. Studies on the Physiological Functions of the Melanocortin System. Nature Reviews Endocrinology.

An influential review describing melanocortin receptor biology, hypothalamic regulation, appetite control, and neuroendocrine signaling.

PubMed – PT-141 (Bremelanotide) Research

A continually updated collection of peer-reviewed publications examining PT-141 across melanocortin receptor biology, neuroendocrinology, autonomic physiology, metabolism, and translational clinical research.

Research Use Statement

For Research Use Only.

PT-141 supplied by Performance Pharma is intended exclusively for laboratory and scientific research conducted by qualified professionals. This product is not approved for human or veterinary use and is not intended to diagnose, treat, cure, or prevent any disease. It should be handled, stored, and used in accordance with applicable laws, regulations, and accepted laboratory research practices.